Anti-EHV-1 glycoprotein I/gI Polyclonal Antibody
Biological Function:
The Anti-EHV-1 glycoprotein I/gI Polyclonal Antibody is a highly specific and sensitive antibody that targets the glycoprotein I/gI of the Equine Herpesvirus 1 (EHV-1). This glycoprotein plays a crucial role in the viral entry and spread within the host, making it an important target for immune response.
Main Applications:
This polyclonal antibody is primarily used for the detection and quantification of EHV-1 in biological samples. It can also be used for immunostaining and immunoblotting techniques to study the expression and localization of the glycoprotein I/gI in infected cells.
Experimental Use Cases:
The Anti-EHV-1 glycoprotein I/gI Polyclonal Antibody has been extensively used in research studies to understand the pathogenesis of EHV-1 and to develop effective diagnostic and therapeutic strategies. It has also been used in vaccine development studies to evaluate the immune response against EHV-1.
Structure:
This antibody is produced in rabbits through immunization with a recombinant EHV-1 glycoprotein I/gI protein. It has been purified using affinity chromatography and has a high affinity for the target antigen. The antibody is supplied as a liquid solution in phosphate-buffered saline (PBS) with 0.09% sodium azide as a preservative.
Keywords: Anti-EHV-1 glycoprotein I/gI Polyclonal Antibody, Equine Herpesvirus 1, glycoprotein I/gI, immune response, diagnostic, therapeutic, vaccine development, affinity chromatography, liquid solution, PBS.
In conclusion, the Anti-EHV-1 glycoprotein I/gI Polyclonal Antibody is a specialized tool for the detection, quantification, and study of EHV-1. Its high specificity and sensitivity, along with its various applications and experimental use cases, make it a valuable asset for researchers in the biotech industry. Trust in the power of this antibody to advance your understanding of EHV-1 and develop effective solutions for this viral infection.
There are no reviews yet.